Engineered CAR T Cells Targeting the Cancer-Associated Tn-Glycoform of the Membrane Mucin MUC1 Control Adenocarcinoma
Avery D. Posey(Parker Institute for Cancer Immunotherapy), Robert D. Schwab(Abramson Cancer Center), Alina C. Boesteanu(Abramson Cancer Center), Catharina Steentoft(University of Copenhagen), Ulla Mandel(University of Copenhagen), Boris Engels(University of Chicago), Jennifer D. Stone(University of Illinois Urbana-Champaign), Thomas D. Madsen(University of Copenhagen), Karin Schreiber(University of Chicago), Kathleen M. Haines(Abramson Cancer Center), Alexandria P. Cogdill(Abramson Cancer Center), Taylor J Chen(Abramson Cancer Center), Decheng Song(Abramson Cancer Center), John Scholler(Abramson Cancer Center), David M. Kranz(University of Illinois Urbana-Champaign), Michael D. Feldman(University of Pennsylvania), Regina M. Young(Abramson Cancer Center), Brian Keith(Abramson Cancer Center), Hans Schreiber(University of Chicago), Henrik Clausen(University of Copenhagen), Laura A. Johnson(Parker Institute for Cancer Immunotherapy), Carl H. June(Abramson Cancer Center)
Cited by 584Open Access